These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 26428663)

  • 1. The Val142Ile transthyretin cardiac amyloidosis: not only an Afro-American pathogenic variant? A single-centre Italian experience.
    Cappelli F; Frusconi S; Bergesio F; Grifoni E; Fabbri A; Giuliani C; Falconi S; Bonifacio S; Perfetto F
    J Cardiovasc Med (Hagerstown); 2016 Feb; 17(2):122-5. PubMed ID: 26428663
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence and Outcomes of p.Val142Ile
    Chandrashekar P; Alhuneafat L; Mannello M; Al-Rashdan L; Kim MM; Dungu J; Alexander K; Masri A
    Circ Genom Precis Med; 2021 Oct; 14(5):e003356. PubMed ID: 34461737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First description of Portuguese patients with cardiac amyloidosis and p.Val142Ile: more evidence of an "African variant" in Caucasians.
    da Costa CM; Amador AF; Calvão J; Vasconcelos Porto A; Fernandes S; Martins E; Macedo F
    Scand Cardiovasc J; 2023 Dec; 57(1):2197183. PubMed ID: 37029471
    [No Abstract]   [Full Text] [Related]  

  • 4. Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy.
    Mazzarotto F; Argirò A; Zampieri M; Magri C; Giotti I; Boschi B; Frusconi S; Gennarelli M; Buxbaum J; Polimanti R; Olivotto I; Perfetto F; Cappelli F
    Eur J Hum Genet; 2023 May; 31(5):541-547. PubMed ID: 36380086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Description of a large cohort of Caucasian patients with V122I ATTRv amyloidosis: Neurological and cardiological features.
    Gentile L; Di Bella G; Minutoli F; Cucinotta F; Obici L; Mussinelli R; Arimatea I; Russo M; Toscano A; Vita G; Mazzeo A
    J Peripher Nerv Syst; 2020 Sep; 25(3):273-278. PubMed ID: 32395865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of cardiac involvement, extracardiac manifestations and outcomes between homozygote and heterozygote transthyretin p.Val142Ile (V122I) variant in patients with hereditary transthyretin amyloidosis: a cohort study.
    Albenque G; Bézard M; Kharoubi M; Odouard S; Lunati A; Poullot E; Zaroui A; Teiger E; Hittinger L; Audard V; El Karoui K; Funalot B; Fanen P; Damy T; Oghina S
    Amyloid; 2023 Dec; 30(4):407-415. PubMed ID: 37377439
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization and natural history of different phenotypes in hereditary transthyretin amyloidosis: 40-year experience at a single Italian referral centre.
    Caponetti AG; Sguazzotti M; Accietto A; Saturi G; Ponziani A; Giovannetti A; Massa P; Ruotolo I; Sena G; Zaccaro A; Parisi V; Bonfiglioli R; Guaraldi P; Gagliardi C; Cortelli P; Galie N; Biagini E; Longhi S
    Eur J Prev Cardiol; 2024 May; 31(7):866-876. PubMed ID: 38204330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early Detection of Cardiac Amyloidosis in Transthyretin Mutation Carriers.
    Nagano N; Muranaka A; Nishikawa R; Ohwada W; Kouzu H; Kamiyama N; Fujito T; Mochizuki A; Nagahara D; Nakanishi M; Ohkubo Y; Hisahara S; Nakao S; Katoh N; Ishikawa A; Sakurai A; Yano T
    Int Heart J; 2022; 63(1):168-175. PubMed ID: 35095067
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Established and candidate transthyretin amyloidosis variants identified in the Saudi population by data mining.
    Abouelhoda M; Mohty D; Alayary I; Meyer BF; Arold ST; Fadel BM; Monies D
    Hum Genomics; 2021 Aug; 15(1):52. PubMed ID: 34380564
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heart transplantation in Val142Ile mutation in the modern era: A single center experience.
    Lyle MA; Brown MT; Morris AA; Gupta D; Vega JD; Cole RT; Bhatt KN
    Clin Transplant; 2022 Nov; 36(11):e14780. PubMed ID: 35848634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Transthyretin Amyloidosis Presenting With Upper-Extremity Neuropathy and Paucity of Autonomic Impairment.
    Devarapalli S; Zhou DJ; Dyck PJB; Piccione EA
    J Clin Neuromuscul Dis; 2019 Jun; 20(4):207-209. PubMed ID: 31135624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of the V122I Hereditary Transthyretin Amyloidosis Genetic Variant With Heart Failure Among Individuals of African or Hispanic/Latino Ancestry.
    Damrauer SM; Chaudhary K; Cho JH; Liang LW; Argulian E; Chan L; Dobbyn A; Guerraty MA; Judy R; Kay J; Kember RL; Levin MG; Saha A; Van Vleck T; Verma SS; Weaver J; Abul-Husn NS; Baras A; Chirinos JA; Drachman B; Kenny EE; Loos RJF; Narula J; Overton J; Reid J; Ritchie M; Sirugo G; Nadkarni G; Rader DJ; Do R
    JAMA; 2019 Dec; 322(22):2191-2202. PubMed ID: 31821430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Three patients of transthyretin amyloidosis in a Japanese family with amyloidogenic transthyretin Thr49Ser (p.Thr69Ser) variant.
    Ikura H; Kitakata H; Endo J; Moriyama H; Sano M; Tsujikawa H; Sawano M; Masuda T; Ohki T; Ueda M; Kosaki K; Fukuda K
    Eur J Med Genet; 2022 Mar; 65(3):104451. PubMed ID: 35149236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
    Coelho T; Maurer MS; Suhr OB
    Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of
    Lopes LR; Futema M; Akhtar MM; Lorenzini M; Pittman A; Syrris P; Elliott PM
    Amyloid; 2019 Dec; 26(4):243-247. PubMed ID: 31554435
    [No Abstract]   [Full Text] [Related]  

  • 16. Sporadic Cardiac Amyloidosis by Amyloidogenic Transthyretin V122I Variant.
    Nehashi T; Oikawa M; Amami K; Kanno Y; Yokokawa T; Misaka T; Yamada S; Kunii H; Nakazato K; Ishida T; Takeishi Y
    Int Heart J; 2019 Nov; 60(6):1441-1443. PubMed ID: 31666456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hereditary cardiac amyloidosis associated with Pro24Ser transthyretin mutation: a case report.
    Yamamoto H; Hashimoto T; Kawamura S; Hiroe M; Yamashita T; Ando Y; Yokochi T
    J Med Case Rep; 2018 Dec; 12(1):370. PubMed ID: 30553273
    [TBL] [Abstract][Full Text] [Related]  

  • 18. TTR variants in patients with dilated cardiomyopathy: An investigation of the DCM Precision Medicine Study.
    Trachtenberg BH; Jimenez J; Morris AA; Kransdorf E; Owens A; Fishbein DP; Jordan E; Kinnamon DD; Mead JO; Huggins GS; Hershberger RE;
    Genet Med; 2022 Jul; 24(7):1495-1502. PubMed ID: 35438637
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rare variant (p.Ser43Asn) of familial transthyretin amyloidosis associated with isolated cardiac phenotype: A case series with literature review.
    Papathanasiou M; Carpinteiro A; Kersting D; Jakstaite AM; Hagenacker T; Schlosser TW; Rischpler C; Rassaf T; Luedike P
    Mol Genet Genomic Med; 2021 Dec; 9(12):e1581. PubMed ID: 33345470
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnosis of genetic amyloidosis through the analysis of transthyretin gene mutation using high-resolution melting.
    Lahuerta C; Menao S; Gracia-Gutierrez A; Bueno-Juana E; Guillén N; Sorribas V; Gracia AA; Aibar MA
    Int J Cardiol; 2020 Feb; 301():220-225. PubMed ID: 31740141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.